Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3976
Alamar Biosciences
ALMR
$2.17B
| $178K | ﹤0.01% |
5,237
+2,050
| +64% | +$60.4K |
2026 Q2
1 quarter
|
|
3977
Vanguard Total International Stock ETF
VXUS
$163B
| $178K | ﹤0.01% |
2,100
-156,601
| -99% | -$13.5M |
2020 Q2
25 quarters
|
|
3978
Innovator Equity Defined Protection ETF - 2 Yr to July 2028
AJUL
$98.5M
| $178K | ﹤0.01% |
5,905
| – | – |
2024 Q4
7 quarters
|
|
3979
Alvotech
ALVO
$1.77B
| $178K | ﹤0.01% |
30,727
+6,370
| +26% | +$27.9K |
2024 Q4
7 quarters
|
|
3980
FB Bancorp
FBLA
$240M
| $178K | ﹤0.01% |
10,799
+5,414
| +101% | +$85K |
2025 Q1
6 quarters
|
|
3981
Arcturus Therapeutics
ARCT
$269M
| $178K | ﹤0.01% |
12,983
-792
| -6% | -$8.28K |
2019 Q3
28 quarters
|
|
3982
FT Vest US Equity Enhance & Moderate Buffer ETF November
XNOV
$25.5M
| $178K | ﹤0.01% |
4,384
| – | – |
2024 Q3
8 quarters
|
|
3983
Aspen Aerogels
ASPN
$530M
| $177K | ﹤0.01% |
32,385
+15,430
| +91% | +$80.5K |
2020 Q2
25 quarters
|
|
3984
FT Vest U.S. Equity Buffer & Digital Return ETF - October
DGOC
$4.95M
| $177K | ﹤0.01% |
5,380
| – | – |
2025 Q4
3 quarters
|
|
3985
Kaltura
KLTR
$227M
| $177K | ﹤0.01% |
138,574
+19,757
| +17% | +$28.7K |
2022 Q3
16 quarters
|
|
3986
Phoenix Education Partners
PXED
$704M
| $177K | ﹤0.01% |
6,942
-1,535
| -18% | -$44.5K |
2025 Q4
3 quarters
|
|
3987
Consolidated Water Co
CWCO
$411M
| $176K | ﹤0.01% |
6,293
+3,806
| +153% | +$111K |
2022 Q3
16 quarters
|
|
3988
Virgin Galactic
SPCE
$435M
| $176K | ﹤0.01% |
58,911
+20,930
| +55% | +$60.8K |
2022 Q1
18 quarters
|
|
3989
Capital Bancorp
CBNK
$690M
| $175K | ﹤0.01% |
4,462
+2,934
| +192% | +$107K |
2018 Q4
31 quarters
|
|
3990
Lexicon Pharmaceuticals
LXRX
$837M
| $175K | ﹤0.01% |
93,199
-294,284
| -76% | -$656K |
2013 Q2
53 quarters
|
|
3991
Citizens & Northern Corp
CZNC
$505M
| $175K | ﹤0.01% |
6,975
+4,437
| +175% | +$111K |
2016 Q1
42 quarters
|
|
3992
Karat Packaging
KRT
$750M
| $174K | ﹤0.01% |
3,317
-16,654
| -83% | -$743K |
2022 Q1
18 quarters
|
|
3993
Hawthorn Bancshares
HWBK
$288M
| $174K | ﹤0.01% |
4,568
+1,414
| +45% | +$55.1K |
2024 Q3
8 quarters
|
|
3994
Blend Labs
BLND
$248M
| $173K | ﹤0.01% |
168,219
+47,401
| +39% | +$73.8K |
2024 Q1
10 quarters
|
|
3995
Innovator Equity Dual Directional 15 Buffer ETF - March
DDFM
$47.6M
| $173K | ﹤0.01% |
8,569
-1,535
| -15% | -$30.6K |
2026 Q2
1 quarter
|
|
3996
Chain Bridge Bancorp
CBNA
$343M
| $172K | ﹤0.01% |
3,740
+676
| +22% | +$30.7K |
2025 Q2
5 quarters
|
|
3997
FT Vest US Equity Deep Buffer ETF January
DJAN
$462M
| $172K | ﹤0.01% |
3,690
| – | – |
2026 Q2
1 quarter
|
|
3998
Contango Silver & Gold Inc
CTGO
$481M
| $171K | ﹤0.01% |
10,192
+6,039
| +145% | +$109K |
2023 Q4
11 quarters
|
|
3999
Nuvectis Pharma
NVCT
$716M
| $171K | ﹤0.01% |
8,096
+5,035
| +164% | +$106K |
2023 Q2
13 quarters
|
|
4000
CALL
O'Reilly Automotive
ORLY
$72.4B
| $171K | ﹤0.01% |
+2,000
| New | +$176K |
2026 Q3
0 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.